{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:38:47Z","timestamp":1787881127857,"version":"build-2784847793"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12975-023-01185-x","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:02:21Z","timestamp":1692288141000},"page":"1005-1014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors Influencing Collateral Circulation Formation After Indirect Revascularization for Moyamoya Disease: a Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Gan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-bin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and Moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337. https:\/\/doi.org\/10.1056\/NEJMra0804622.","journal-title":"N Engl J Med."},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: Current concepts and future perspectives. Lancet Neurol. 2008;7:1056\u201366. https:\/\/doi.org\/10.1016\/S1474-4422(08)70240-0.","journal-title":"Lancet Neurol."},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012.","journal-title":"Arch Neurol."},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2015.01739","volume":"18","author":"T Kim","year":"2016","unstructured":"Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: Treatment and outcomes. J Stroke. 2016;18:21\u201330. https:\/\/doi.org\/10.5853\/jos.2015.01739.","journal-title":"J Stroke."},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","volume":"79","author":"T Baba","year":"2008","unstructured":"Baba T, Houkin K, Kuroda S. Novel epidemiological features of Moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900\u20134. https:\/\/doi.org\/10.1136\/jnnp.2007.130666.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A. Moyamoya disease: Diagnosis and interventions. Lancet Neurol. 2022;21:747\u201358. https:\/\/doi.org\/10.1016\/S1474-4422(22)00165-X.","journal-title":"Lancet Neurol."},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000343225","volume":"34","author":"XY Bao","year":"2012","unstructured":"Bao XY, Duan L, Li DS, Yang WZ, Sun WJ, Zhang ZS, Zong R, Han C. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China. Cerebrovasc Dis. 2012;34:305\u201313. https:\/\/doi.org\/10.1159\/000343225.","journal-title":"Cerebrovasc Dis."},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000369524","volume":"39","author":"XY Bao","year":"2015","unstructured":"Bao XY, Duan L, Yang WZ, Li DS, Sun WJ, Zhang ZS, Zong R, Han C. Clinical features, surgical treatment, and long-term outcome in pediatric patients with Moyamoya disease in China. Cerebrovasc Dis. 2015;39:75\u201381. https:\/\/doi.org\/10.1159\/000369524.","journal-title":"Cerebrovasc Dis."},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1227\/NEU.0b013e3181fc5ec2","volume":"68","author":"JR Dusick","year":"2011","unstructured":"Dusick JR, Gonzalez NR, Martin NA. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: A review of 63 procedures. Neurosurg. 2011;68:34\u201343. https:\/\/doi.org\/10.1227\/NEU.0b013e3181fc5ec2.","journal-title":"Neurosurg."},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0090-3019(91)90022-2","volume":"36","author":"Y Matsushima","year":"1991","unstructured":"Matsushima Y, Aoyagi M, Suzuki R, Tabata H, Ohno K. Perioperative complications of encephaloduro-arterio-synangiosis: Prevention and treatment. Surg Neurol. 1991;36:343\u201353. https:\/\/doi.org\/10.1016\/0090-3019(91)90022-2.","journal-title":"Surg Neurol."},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3345\/kjp.2012.55.11.408","volume":"55","author":"KC Wang","year":"2012","unstructured":"Wang KC, Phi JH, Lee JY, Kim SK, Cho BK. Indirect revascularization surgery for Moyamoya disease in children and its special considerations. Korean J Pediatr. 2012;55:408\u201313. https:\/\/doi.org\/10.3345\/kjp.2012.55.11.408.","journal-title":"Korean J Pediatr."},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s007010050035","volume":"142","author":"K Houkin","year":"2000","unstructured":"Houkin K, Kuroda S, Ishikawa T, Abe H. Neovascularization (angiogenesis) after revascularization in Moyamoya disease. Which technique is most useful for moyamoya disease? Acta Neurochir (Wien). 2000;142:269\u201376. https:\/\/doi.org\/10.1007\/s007010050035.","journal-title":"Acta Neurochir (Wien)."},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ana.21981","volume":"68","author":"SK Kim","year":"2010","unstructured":"Kim SK, Cho BK, Phi JH, Lee JY, Chae JH, Kim KJ, Hwang YS, Kim IO, Lee DS, Lee J, Wang KC. Pediatric Moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol. 2010;68:92\u2013101. https:\/\/doi.org\/10.1002\/ana.21981.","journal-title":"Ann Neurol."},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.str.31.4.930","volume":"31","author":"T Yamauchi","year":"2000","unstructured":"Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M. Linkage of familial Moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930\u20135. https:\/\/doi.org\/10.1161\/01.str.31.4.930.","journal-title":"Stroke."},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M, Gu Y. Molecular analysis of RNF213 gene for Moyamoya disease in the Chinese Han population. PLOS ONE. 2012;7:e48179. https:\/\/doi.org\/10.1371\/journal.pone.0048179.","journal-title":"PLOS ONE."},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Gent. 2011;56:34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132.","journal-title":"J Hum Gent."},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/STROKEAHA.117.017430","volume":"49","author":"L Duan","year":"2018","unstructured":"Duan L, Wei L, Tian Y, Zhang Z, Hu P, Wei Q, Liu S, Zhang J, Wang Y, Li D, Yang W, Zong R, Xian P, Han C, Bao X, Zhao F, Feng J, Liu W, Cao W, et al. Novel susceptibility loci for Moyamoya disease revealed by a genome-wide association study. Stroke. 2018;49:11\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017430.","journal-title":"Stroke."},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, et al. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurol. 2012;78:803\u201310. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f.","journal-title":"Neurol."},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3171\/2016.2.JNS152173","volume":"126","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Liu Y, Zhang D, Wang R, Zhang Y, Wang S, Yu L, Lu C, Liu F, Zhou J, Zhang X, Zhao J. RNF213 as the major susceptibility gene for Chinese patients with Moyamoya disease and its clinical relevance. J Neurosurg. 2017;126:1106\u201313. https:\/\/doi.org\/10.3171\/2016.2.JNS152173.","journal-title":"J Neurosurg."},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3171\/2015.4.JNS142900","volume":"124","author":"EH Kim","year":"2016","unstructured":"Kim EH, Yum MS, Ra YS, Park JB, Ahn JS, Kim GH, Goo HW, Ko TS, Yoo HW. Importance of RNF213 polymorphism on clinical features and longterm outcome in Moyamoya disease. J Neurosurg. 2016;124:1221\u20137. https:\/\/doi.org\/10.3171\/2015.4.JNS142900.","journal-title":"J Neurosurg."},{"key":"1185_CR21","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1136\/jnnp-2020-325401","volume":"92","author":"QN Wang","year":"2021","unstructured":"Wang QN, Yang RM, Zou ZX, Wang XP, Zhang Q, Li DS, Bao XY, Duan L. Predictors of neoangiogenesis after indirect revascularisation in Moyamoya disease: A 10-year follow-up study. J Neurol Neurosurg Psychiatry. 2021;92:1361\u20132. https:\/\/doi.org\/10.1136\/jnnp-2020-325401.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1185_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.14184","volume":"27","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J. Angiographic characteristics in Moyamoya disease with the p.R4810K variant: A propensity score-matched analysis. Eur J Neurol. 2020;27:856\u201363. https:\/\/doi.org\/10.1111\/ene.14184.","journal-title":"Eur J Neurol."},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.wneu.2016.09.018","volume":"96","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Wang R, Liu Y, Zhang Y, Wang S, Cao Y, Zhao Y, Liu X, Wang J, Deng X, Gao F, Yang Z, Zhao M, Ge P, Ma Y, Zhao J, Zhang D. Clinical features and long-term outcomes of unilateral Moyamoya disease. World Neurosurg. 2016;96:474\u201382. https:\/\/doi.org\/10.1016\/j.wneu.2016.09.018.","journal-title":"World Neurosurg."},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000503250","volume":"48","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhang Q, Zhao J. Association between p.R4810k variant and postoperative collateral formation in patients with Moyamoya disease. Cerebrovasc Dis. 2019;48:1\u20138. https:\/\/doi.org\/10.1159\/000503250.","journal-title":"Cerebrovasc Dis."},{"key":"1185_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Gen. 1995;10:111\u20133. https:\/\/doi.org\/10.1038\/ng0595-111.","journal-title":"Nat Gen."},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00394-015-1076-x","volume":"56","author":"NJ Colson","year":"2017","unstructured":"Colson NJ, Naug HL, Nikbakht E, Zhang P, McCormack J. The impact of MTHFR 677 C\/T genotypes on folate status markers: A meta-analysis of folic acid intervention studies. Eur J Nutr. 2017;56:247\u201360. https:\/\/doi.org\/10.1007\/s00394-015-1076-x.","journal-title":"Eur J Nutr."},{"key":"1185_CR27","doi-asserted-by":"publisher","first-page":"21687","DOI":"10.3390\/ijms151221687","volume":"15","author":"B Yang","year":"2014","unstructured":"Yang B, Fan S, Zhi X, Wang D, Li Y, Wang Y, Wang Y, Wei J, Zheng Q, Sun G. Associations of MTHFR C677T and MTRR A66G gene polymorphisms with metabolic syndrome: A case-control study in Northern China. Int J Mol Sci. 2014;15:21687\u2013702. https:\/\/doi.org\/10.3390\/ijms151221687.","journal-title":"Int J Mol Sci."},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.metabol.2010.05.001","volume":"59","author":"R Dankner","year":"2010","unstructured":"Dankner R, Chetrit A, Murad H, Sela BA, Frystyk J, Raz I, Flyvbjerg A, et al. Serum adiponectin is associated with homocysteine in elderly men and women, and with 5,10-methylenetetrahydrofolate reductase (MTHFR) in a sex-dependent manner. Metab Clin Exp. 2010;59:1767\u201374. https:\/\/doi.org\/10.1016\/j.metabol.2010.05.001.","journal-title":"Metab Clin Exp."},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(05)17742-3","volume":"365","author":"JP Casas","year":"2005","unstructured":"Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: Evidence on a causal link from Mendelian randomization. Lancet. 2005;365:224\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(05)17742-3.","journal-title":"Lancet."},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/j.ajkd.2008.12.023","volume":"53","author":"RL Jamison","year":"2009","unstructured":"Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P. Veterans Affairs Site Investigators. Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: A prospective study. Am J Kidney Dis. 2009;53:779\u201389. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.023.","journal-title":"Am J Kidney Dis."},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1001\/jama.288.16.2023","volume":"288","author":"M Klerk","year":"2002","unstructured":"Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR Studies Collaboration Group. 677C\u2013>T polymorphism and risk of coronary heart disease: A meta-analysis. JAMA. 2002;288:2023\u201331. https:\/\/doi.org\/10.1001\/jama.288.16.2023.","journal-title":"JAMA."},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.nut.2012.09.015","volume":"29","author":"A Chmurzynska","year":"2013","unstructured":"Chmurzynska A, Malinowska AM, Twardowska-Rajewska J, Gawecki J. Elderly women: Homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism). Nutrition. 2013;29:841\u20134. https:\/\/doi.org\/10.1016\/j.nut.2012.09.015.","journal-title":"Nutrition."},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/qjmed\/hcg039","volume":"96","author":"R Castro","year":"2003","unstructured":"Castro R, Rivera I, Ravasco P, Jakobs C, Blom HJ, Camilo ME, de Almeida IT. 5,10-Methylenetetrahydrofolate reductase 677C\u2013>T and 1298A\u2013>C mutations are genetic determinants of elevated homocysteine. QJM. 2003;96:297\u20133. https:\/\/doi.org\/10.1093\/qjmed\/hcg039.","journal-title":"QJM."},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.3390\/ijms15058931","volume":"15","author":"BS Zhou","year":"2014","unstructured":"Zhou BS, Bu GY, Li M, Chang BG, Zhou YP. Tagging SNPs in the MTHFR gene and risk of ischemic stroke in a Chinese population. International J Mol Sci. 2014;15:8931\u201340. https:\/\/doi.org\/10.3390\/ijms15058931.","journal-title":"International J Mol Sci."},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1186\/1471-2458-11-733","volume":"11","author":"F Marti","year":"2011","unstructured":"Marti F, Vollenweider P, Marques-Vidal PM, Mooser V, Waeber G, Paccaud F, Bochud M. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health. 2011;11:733. https:\/\/doi.org\/10.1186\/1471-2458-11-733.","journal-title":"BMC Public Health."},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/hupa.2003.56","volume":"34","author":"S La Rosa","year":"2003","unstructured":"La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: Correlation with microvessel density and clinicopathologic features. Hum Pathol. 2003;34:18\u201327. https:\/\/doi.org\/10.1053\/hupa.2003.56.","journal-title":"Hum Pathol."},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1161\/01.cir.93.8.1493","volume":"93","author":"V Vincenti","year":"1996","unstructured":"Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93:1493\u20135. https:\/\/doi.org\/10.1161\/01.cir.93.8.1493.","journal-title":"Circulation."},{"key":"1185_CR38","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306\u20139. https:\/\/doi.org\/10.1126\/science.2479986.","journal-title":"Science."},{"key":"1185_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843\u20135. https:\/\/doi.org\/10.1038\/359843a0.","journal-title":"Nature."},{"key":"1185_CR40","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/01.str.27.10.1865","volume":"27","author":"Z Kov\u00e1cs","year":"1996","unstructured":"Kov\u00e1cs Z, Ikezaki K, Samoto K, Inamura T, Fukui M, VEGF and FLT. Expression time kinetics in rat brain infarct. Stroke. 1996;27:1865\u201372. https:\/\/doi.org\/10.1161\/01.str.27.10.1865.","journal-title":"Stroke."},{"key":"1185_CR41","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1161\/01.str.28.10.2039","volume":"28","author":"T Hayashi","year":"1997","unstructured":"Hayashi T, Abe K, Suzuki H, Itoyama Y. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. Stroke. 1997;28:2039\u201344. https:\/\/doi.org\/10.1161\/01.str.28.10.2039.","journal-title":"Stroke."},{"key":"1185_CR42","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/00005072-199809000-00009","volume":"57","author":"F Lennmyr","year":"1998","unstructured":"Lennmyr F, Ata KA, Funa K, Olsson Y, Ter\u00e9nt A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol. 1998;57:874\u201382. https:\/\/doi.org\/10.1097\/00005072-199809000-00009.","journal-title":"J Neuropathol Exp Neurol."},{"key":"1185_CR43","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0198-8859(99)00132-9","volume":"60","author":"IJ Brogan","year":"1999","unstructured":"Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5\u2019 UTR regions of the human vascular endothelial growth factor gene. Hum Immunol. 1999;60:1245\u20139. https:\/\/doi.org\/10.1016\/s0198-8859(99)00132-9.","journal-title":"Hum Immunol."},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","volume":"51","author":"T Awata","year":"2002","unstructured":"Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S. A common polymorphism in the 5\u2019-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51:1635\u20139. https:\/\/doi.org\/10.2337\/diabetes.51.5.1635.","journal-title":"Diabetes."},{"key":"1185_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1159\/000054076","volume":"37","author":"W Renner","year":"2000","unstructured":"Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C\/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37:443\u20138. https:\/\/doi.org\/10.1159\/000054076.","journal-title":"J Vasc Res."},{"key":"1185_CR46","doi-asserted-by":"publisher","first-page":"e47158","DOI":"10.1371\/journal.pone.0047158","volume":"7","author":"YS Park","year":"2012","unstructured":"Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH, Han IB, Kim HS, Kim WC, Kim OJ, Kim TG, Choi JU, Kim DS, Kim NK. The role of VEGF and KDR polymorphisms in Moyamoya disease and collateral revascularization. PloS One. 2012;7:e47158. https:\/\/doi.org\/10.1371\/journal.pone.0047158.","journal-title":"PloS One."},{"key":"1185_CR47","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1038\/s41467-020-18538-x","volume":"11","author":"J Oh","year":"2020","unstructured":"Oh J, Matkovich SJ, Riek AE, Bindom SM, Shao JS, Head RD, Barve RA, Sands MS, Carmeliet G, Osei-Owusu P, Knutsen RH, Zhang H, Blumer KJ, Nichols CG, Mecham RP, Bald\u00e1n \u00c1, Benitez BA, Sequeira-Lopez ML, Gomez RA, Bernal-Mizrachi C. Macrophage secretion of mir- 106b-5p causes renin-dependent hypertension. Nature Comm. 2020;11:4798. https:\/\/doi.org\/10.1038\/s41467-020-18538-x.","journal-title":"Nature Comm."},{"key":"1185_CR48","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/CIRCRESAHA.120.317796","volume":"127","author":"I Parra-Izquierdo","year":"2020","unstructured":"Parra-Izquierdo I, McCarty OJT, Aslan JE. Platelet mir-223 delivery rescues vascular cells in Kawasaki disease. Circ Res. 2020;127:874\u20136. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317796.","journal-title":"Circ Res."},{"key":"1185_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.brainresbull.2020.09.003","volume":"165","author":"X Sun","year":"2020","unstructured":"Sun X, Zheng X, Zhang X, Zhang Y, Luo G. Exosomal microrna-23b-3p from bone marrow mesenchymal stem cells maintains T helper\/Treg balance by downregulating the pi3k\/akt\/nf-kappab signaling pathway in intracranial aneurysm. Brain Res Bull. 2020;165:305\u201315. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.09.003.","journal-title":"Brain Res Bull."},{"key":"1185_CR50","doi-asserted-by":"publisher","first-page":"548278","DOI":"10.3389\/fnins.2020.548278","volume":"14","author":"G Wang","year":"2020","unstructured":"Wang G, Wen Y, Faleti OD, Zhao Q, Liu J, Zhang G, Li M, Qi S, Feng W, Lyu X. A panel of exosome-derived mirnas of cerebrospinal fluid for the diagnosis of Moyamoya disease. Front Neurosci. 2020;14:548278. https:\/\/doi.org\/10.3389\/fnins.2020.548278.","journal-title":"Front Neurosci."},{"key":"1185_CR51","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1111\/jcmm.13700","volume":"22","author":"LL Sun","year":"2018","unstructured":"Sun LL, Li WD, Lei FR, Li XQ. The regulatory role of microRNAs in angiogenesis-related diseases. J Cell Mol Med. 2018;22:4568\u201387. https:\/\/doi.org\/10.1111\/jcmm.13700.","journal-title":"J Cell Mol Med."},{"key":"1185_CR52","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.119.315886","volume":"126","author":"P Sun","year":"2020","unstructured":"Sun P, Zhang K, Hassan SH, Zhang X, Tang X, Pu H, Stetler RA, Chen J, Yin KJ. Endothelium-targeted deletion of microrna-15a\/16-1 promotes poststroke angiogenesis and improves long-term neurological recovery. Circ Res. 2020;126:1040\u201357. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315886.","journal-title":"Circ Res."},{"key":"1185_CR53","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1002\/jcb.26545","volume":"119","author":"M Fang","year":"2018","unstructured":"Fang M, Wang CG, Zheng C, Luo J, Hou S, Liu K, Li X. Mir-29b promotes human aortic valve interstitial cell calcification via inhibiting tgf-beta3 through activation of wnt3\/beta-catenin\/smad3 signaling. J Cell Biochem. 2018;119:5175\u201385. https:\/\/doi.org\/10.1002\/jcb.26545.","journal-title":"J Cell Biochem."},{"key":"1185_CR54","doi-asserted-by":"publisher","first-page":"13234","DOI":"10.18632\/aging.103431","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen C, Ling C, Gong J, Li C, Zhang L, Gao S, Li Z, Huang T, Wang H, Guo Y. Increasing the expression of microRNA-126-5p in the temporal muscle can promote angiogenesis in the chronically ischemic brains of rats subjected to two-vessel occlusion plus encephalo-myo-synangiosis. Aging. 2020;12:13234\u201354. https:\/\/doi.org\/10.18632\/aging.103431.","journal-title":"Aging."},{"key":"1185_CR55","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/cns.13646","volume":"27","author":"G Wang","year":"2021","unstructured":"Wang G, Wen Y, Chen S, Zhang G, Li M, Zhang S, Qi S, Feng W. Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in Moyamoya disease. CNS Neurosci Therapeut. 2021;27:908\u201318. https:\/\/doi.org\/10.1111\/cns.13646.","journal-title":"CNS Neurosci Therapeut."},{"key":"1185_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/1747493016662039","volume":"11","author":"OY Bang","year":"2016","unstructured":"Bang OY, Chung JW, Kim SJ, Oh MJ, Kim SY, Cho YH, Cha J, Yeon JY, Kim KH, Kim GM, Chung CS, Lee KH, Ki CS, Jeon P, Kim JS, Hong SC, Moon GJ. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease. Int J Stroke. 2016;11:999\u20131008. https:\/\/doi.org\/10.1177\/1747493016662039.","journal-title":"Int J Stroke."},{"key":"1185_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T. Genetics and biomarkers of Moyamoya disease: Significance of RNF213 as a susceptibility gene. J Stroke. 2014;16:65\u201372. https:\/\/doi.org\/10.5853\/jos.2014.16.2.65.","journal-title":"J Stroke."},{"key":"1185_CR58","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/ijms22041696","volume":"22","author":"YC Fang","year":"2021","unstructured":"Fang YC, Wei LF, Hu CJ, Tu YK. Pathological circulating factors in Moyamoya disease. Int J Mol Sci. 2021;22:1696. https:\/\/doi.org\/10.3390\/ijms22041696.","journal-title":"Int J Mol Sci."},{"key":"1185_CR59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK. Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673\u20138. https:\/\/doi.org\/10.1136\/jnnp.2009.191817.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1185_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10143-007-0102-8","volume":"31","author":"S Sakamoto","year":"2008","unstructured":"Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, Sugiyama K, Kurisu K. Expression of vascular endothelial growth factor in dura mater of patients with Moyamoya disease. Neurosurg Rev. 2008;31:77\u201381. https:\/\/doi.org\/10.1007\/s10143-007-0102-8.","journal-title":"Neurosurg Rev."},{"key":"1185_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3892\/etm.2014.1713","volume":"8","author":"J He","year":"2014","unstructured":"He J, Wang R, Zhang D, Zhang Y, Zhang Q, Zhao J. Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with Moyamoya disease. Exp Ther Med. 2014;8:302\u20138. https:\/\/doi.org\/10.3892\/etm.2014.1713.","journal-title":"Exp Ther Med."},{"key":"1185_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrm1911","volume":"7","author":"AK Olsson","year":"2006","unstructured":"Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling\u2014in control of vascular function. Nat Rev Mol Cell Biol. 2006;7:359\u201371. https:\/\/doi.org\/10.1038\/nrm1911.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"1185_CR63","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0304-3940(93)90416-i","volume":"160","author":"A Takahashi","year":"1993","unstructured":"Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with Moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214\u20136. https:\/\/doi.org\/10.1016\/0304-3940(93)90416-i.","journal-title":"Neurosci Lett."},{"key":"1185_CR64","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/01.str.27.12.2160","volume":"27","author":"T Yoshimoto","year":"1996","unstructured":"Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in Moyamoya disease. Stroke. 1996;27:2160\u20135. https:\/\/doi.org\/10.1161\/01.str.27.12.2160.","journal-title":"Stroke."},{"key":"1185_CR65","first-page":"37","volume":"60","author":"K Tokunaga","year":"2008","unstructured":"Tokunaga K, Date I. Moyamoya disease. Brain Nerve. 2008;60:37\u201342.","journal-title":"Brain Nerve."},{"key":"1185_CR66","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/316701a0","volume":"316","author":"R Derynck","year":"1985","unstructured":"Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-b complementary DNA sequence and expression in normal and transformed cells. Nature. 1985;316:701\u20135. https:\/\/doi.org\/10.1038\/316701a0.","journal-title":"Nature."},{"key":"1185_CR67","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm0195-74","volume":"1","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-b is severely depressed in advanced atherosclerosis. Nat Med. 1995;1:74\u20139. https:\/\/doi.org\/10.1038\/nm0195-74.","journal-title":"Nat Med."},{"key":"1185_CR68","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s00701-010-0711-9","volume":"152","author":"C Roder","year":"2010","unstructured":"Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir. 2010;152:2153\u201360. https:\/\/doi.org\/10.1007\/s00701-010-0711-9.","journal-title":"Acta Neurochir."},{"key":"1185_CR69","doi-asserted-by":"publisher","first-page":"640065","DOI":"10.3389\/fcell.2021.640065","volume":"9","author":"Q Lu","year":"2021","unstructured":"Lu Q, Sun D, Shivhare SB, Hou H, Bulmer JN, Innes BA, Hapangama DK, Lash GE. Transforming growth factor (TGF) beta and endometrial vascular maturation. Front Cell Dev Biol. 2021;9:640065. https:\/\/doi.org\/10.3389\/fcell.2021.640065.","journal-title":"Front Cell Dev Biol."},{"key":"1185_CR70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","volume":"89","author":"M Hojo","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, Matsuura N, Ishizaki R, Kikuchi H, Hashimoto N. Role of transforming growth factor-beta1 in the pathogenesis of Moyamoya disease. J Neurosurg. 1998;89:623\u20139. https:\/\/doi.org\/10.3171\/jns.1998.89.4.0623.","journal-title":"J Neurosurg."},{"key":"1185_CR71","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1038\/s41598-017-03278-8","volume":"7","author":"L Weng","year":"2017","unstructured":"Weng L, Cao X, Han L, Zhao H, Qiu S, Yan Y, Wang X, Chen X, Zheng W, Xu X, Gao Y, Chen Y, Li J, Yang Y, Xu Y. Association of increased Treg and Th17 with pathogenesis of Moyamoya disease. Sci Rep. 2017;7:3071. https:\/\/doi.org\/10.1038\/s41598-017-03278-8.","journal-title":"Sci Rep."},{"key":"1185_CR72","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.3171\/2011.3.FOCUS1151","volume":"30","author":"DG Weinberg","year":"2011","unstructured":"Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: A review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30:E20. https:\/\/doi.org\/10.3171\/2011.3.FOCUS1151.","journal-title":"Neurosurg Focus."},{"key":"1185_CR73","doi-asserted-by":"publisher","first-page":"899470","DOI":"10.3389\/fneur.2022.899470","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tang M, Li H, Liu H, Wang J, Huang J. TGF\u03b21 as a predictive biomarker for collateral formation within ischemic Moyamoya disease. Front Neurol. 2022;13:899470. https:\/\/doi.org\/10.3389\/fneur.2022.899470.","journal-title":"Front Neurol."},{"key":"1185_CR74","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3389\/fneur.2019.01267","volume":"10","author":"P Ge","year":"2019","unstructured":"Ge P, Ye X, Liu X, Deng X, Wang J, Wang R, et al. Angiographic outcomes of direct and combined bypass surgery in Moyamoya disease. Front Neurol. 2019;10:1267. https:\/\/doi.org\/10.3389\/fneur.2019.01267.","journal-title":"Front Neurol."},{"key":"1185_CR75","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3171\/2018.5.PEDS18163","volume":"22","author":"N Gadgil","year":"2018","unstructured":"Gadgil N, Lam S, Pyarali M, Paldino M, Pan IW, Dauser RC. Indirect revascularization with the dural inversion technique for pediatric Moyamoya disease: 20-year experience. J Neurosurg Pediatr. 2018;22:541\u20139. https:\/\/doi.org\/10.3171\/2018.5.PEDS18163.","journal-title":"J Neurosurg Pediatr."},{"key":"1185_CR76","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1177\/0271678X18768443","volume":"38","author":"KG Blecharz-Lang","year":"2018","unstructured":"Blecharz-Lang KG, Prinz V, Burek M, Frey D, Schenkel T, Krug SM, Fromm M, Vajkoczy P. Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease. J Cerebr Blood Flow Metab. 2018;38:1940\u201353. https:\/\/doi.org\/10.1177\/0271678X18768443.","journal-title":"J Cerebr Blood Flow Metab."},{"key":"1185_CR77","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, Cho BK, Kim SK. Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J Neurol Neurosurg Psychiatry. 2010;81:673\u20138. https:\/\/doi.org\/10.1136\/jnnp.2009.191817.","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1185_CR78","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3171\/jns.2005.103.5.0882","volume":"103","author":"N Kusaka","year":"2005","unstructured":"Kusaka N, Sugiu K, Tokunaga K, Katsumata A, Nishida A, Namba K, Hamada H, Nakashima H, Date I. Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg. 2005;103:882\u201390. https:\/\/doi.org\/10.3171\/jns.2005.103.5.0882.","journal-title":"J Neurosurg."},{"key":"1185_CR79","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3171\/2015.12.PEDS15448","volume":"18","author":"K Pricola Fehnel","year":"2016","unstructured":"Pricola Fehnel K, Duggins-Warf M, McKee-Proctor M, Majumder R, Raber M, Han X, Smith ER. Using urinary bFGF and TIMP3 levels to predict the presence of juvenile pilocytic astrocytoma and establish a distinct biomarker signature. J Neurosurg Ped. 2016;18:396\u2013407. https:\/\/doi.org\/10.3171\/2015.12.PEDS15448.","journal-title":"J Neurosurg Ped."},{"key":"1185_CR80","doi-asserted-by":"publisher","first-page":"661952","DOI":"10.3389\/fneur.2021.661952","volume":"12","author":"J Sesen","year":"2021","unstructured":"Sesen J, Driscoll J, Moses-Gardner A, Orbach DB, Zurakowski D, Smith ER. Non-invasive urinary biomarkers in Moyamoya disease. Front Neurol. 2021;12:661952. https:\/\/doi.org\/10.3389\/fneur.2021.661952.","journal-title":"Front Neurol."},{"key":"1185_CR81","doi-asserted-by":"publisher","unstructured":"Zhao Y, Li J, Lu J, Zhang Q, Zhang D, Wang R, Zhao Y, Chen X. Predictors of neoangiogenesis after indirect revascularization in Moyamoya disease: A multicenter retrospective study. J Neurosurg. 2019:1\u201311. https:\/\/doi.org\/10.3171\/2018.9.JNS181562.","DOI":"10.3171\/2018.9.JNS181562"},{"key":"1185_CR82","doi-asserted-by":"publisher","first-page":"721118","DOI":"10.3389\/fneur.2021.721118","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Wang J, Lin Z, Shi G, Wang R, Zhao Y, Zhao Y, Zhao J. MMP-9 as a biomarker for predicting hemorrhagic strokes in Moyamoya disease. Front Neurol. 2021;12:721118. https:\/\/doi.org\/10.3389\/fneur.2021.721118.","journal-title":"Front Neurol."},{"key":"1185_CR83","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2176\/nmc.52.267","volume":"52","author":"K Houkin","year":"2012","unstructured":"Houkin K, Ito M, Sugiyama T, Shichinohe H, Nakayama N, Kazumata K, Kuroda S. Review of past research and current concepts on the etiology of Moyamoya disease. Neurol Med Chir. 2012;52:267\u201377. https:\/\/doi.org\/10.2176\/nmc.52.267.","journal-title":"Neurol Med Chir."},{"key":"1185_CR84","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/STROKEAHA.108.529420","volume":"40","author":"N Rafat","year":"2009","unstructured":"Rafat N, Beck GC, Pe\u00f1a-Tapia PG, Schmiedek P, Vajkoczy P. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease. Stroke. 2009;40:432\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.108.529420.","journal-title":"Stroke."},{"key":"1185_CR85","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nm0603-702","volume":"9","author":"S Rafii","year":"2003","unstructured":"Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularisation and regeneration. Nat Med. 2003;9:702\u201312. https:\/\/doi.org\/10.1038\/nm0603-702.","journal-title":"Nat Med."},{"key":"1185_CR86","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","volume":"8","author":"M Hristov","year":"2004","unstructured":"Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8:498\u2013508. https:\/\/doi.org\/10.1111\/j.1582-4934.2004.tb00474.x.","journal-title":"J Cell Mol Med."},{"key":"1185_CR87","doi-asserted-by":"publisher","first-page":"e01035","DOI":"10.1002\/brb3.1035","volume":"8","author":"XY Bao","year":"2018","unstructured":"Bao XY, Fan YN, Liu Y, Wang QN, Zhang Y, Zhu B, Liu B, Duan L. Circulating endothelial progenitor cells and endothelial cells in Moyamoya disease. Brain Behav. 2018;8:e01035. https:\/\/doi.org\/10.1002\/brb3.1035.","journal-title":"Brain Behav."},{"key":"1185_CR88","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12975-020-00834-9","volume":"12","author":"QN Wang","year":"2021","unstructured":"Wang QN, Zou ZX, Wang XP, Zhang Q, Zhao YQ, Duan L, Bao XY. Endothelial progenitor cells induce angiogenesis: A potential mechanism underlying neovascularization in encephaloduroarteriosynangiosis. Transl Stroke Res. 2021;12:357\u201365. https:\/\/doi.org\/10.1007\/s12975-020-00834-9.","journal-title":"Transl Stroke Res."},{"key":"1185_CR89","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.amjcard.2015.08.010","volume":"116","author":"C Qian","year":"2015","unstructured":"Qian C, Wei B, Ding J, Wu H, Cai X, Li B, Wang Y. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques. Am J Cardiol. 2015;116:1521\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2015.08.010.","journal-title":"Am J Cardiol."},{"key":"1185_CR90","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s10495-015-1175-4","volume":"20","author":"A Ahsan","year":"2015","unstructured":"Ahsan A, Han G, Pan J, Liu S, Padhiar AA, Chu P, Sun Z, Zhang Z, Sun B, Wu J, Irshad A, Lin Y, Peng J, Tang Z. Phosphocreatine protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K\/Akt\/eNOS pathway. Apoptosis. 2015;20:1563\u201376. https:\/\/doi.org\/10.1007\/s10495-015-1175-4.","journal-title":"Apoptosis."},{"key":"1185_CR91","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2021.6.FOCUS21112","volume":"51","author":"QN Wang","year":"2021","unstructured":"Wang QN, Bao XY, Zou ZX, Wang XP, Zhang Q, Li DS, Zhao YQ, Duan L. The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: A prospective trial. Neurosurg Focus. 2021;51:E9. https:\/\/doi.org\/10.3171\/2021.6.FOCUS21112.","journal-title":"Neurosurg Focus."},{"key":"1185_CR92","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.ATV.0000070546.16946.3A","volume":"23","author":"PG Frank","year":"2003","unstructured":"Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol. 2003;23:1161\u20138. https:\/\/doi.org\/10.1161\/01.ATV.0000070546.16946.3A.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"1185_CR93","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1074\/jbc.M110354200","volume":"277","author":"J Liu","year":"2002","unstructured":"Liu J, Wang XB, Park DS, Lisanti MP. Caveolin-1 expression enhances endothelial capillary tubule formation. J Biolog Chem. 2002;277:10661\u20138. https:\/\/doi.org\/10.1074\/jbc.M110354200.","journal-title":"J Biolog Chem."},{"key":"1185_CR94","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2353\/ajpath.2009.090171","volume":"175","author":"SH Chang","year":"2009","unstructured":"Chang SH, Feng D, Nagy JA, Sciuto TE, Dvorak AM, Dvorak HF. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. Am J Pathol. 2009;175:1768\u201376. https:\/\/doi.org\/10.2353\/ajpath.2009.090171.","journal-title":"Am J Pathol."},{"key":"1185_CR95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/1747493016662039","volume":"11","author":"OY Bang","year":"2016","unstructured":"Bang OY, Chung JW, Kim SJ, et al. Caveolin-1, Ring fifinger protein 213, and endothelial function in Moyamoya disease. Int J Stroke. 2016;11:999\u20131008.","journal-title":"Int J Stroke"},{"key":"1185_CR96","doi-asserted-by":"publisher","first-page":"796339","DOI":"10.3389\/fneur.2022.796339","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Yu Z, Zhang Y, Qiu C, Zhang G, Chen L, He S, Ma J. Caveolin-1 promoted collateral vessel formation in patients with Moyamoya disease. Front Neurol. 2022;13:796339. https:\/\/doi.org\/10.3389\/fneur.2022.796339.","journal-title":"Front Neurol."},{"key":"1185_CR97","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00011-018-1161-8","volume":"67","author":"S Chaabane","year":"2018","unstructured":"Chaabane S, Messedi M, Akrout R, Ben Hamad M, Turki M, Marzouk S, Keskes L, Bahloul Z, Rebai A, Ayedi F, Maalej A. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients. Inflamm Res. 2018;67:703\u201310. https:\/\/doi.org\/10.1007\/s00011-018-1161-8.","journal-title":"Inflamm Res."},{"key":"1185_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6. https:\/\/doi.org\/10.1186\/1475-2891-14-6.","journal-title":"Nutr J."},{"key":"1185_CR99","doi-asserted-by":"publisher","first-page":"e8627","DOI":"10.7717\/peerj.8627","volume":"8","author":"H Yuan","year":"2020","unstructured":"Yuan H, Fu M, Yang X, Huang K, Ren X. Single nucleotide polymorphism of MTHFR rs1801133 associated with elevated Hcy levels affects susceptibility to cerebral small vessel disease. PeerJ. 2020;8:e8627. https:\/\/doi.org\/10.7717\/peerj.8627.","journal-title":"PeerJ"},{"key":"1185_CR100","doi-asserted-by":"publisher","first-page":"902474","DOI":"10.3389\/fneur.2022.902474","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Ge P, Ye X, Liu X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J. Hyperhomocysteinemia is a predictor for poor postoperative angiogenesis in adult patients with Moyamoya disease. Front Neurol. 2022;13:902474. https:\/\/doi.org\/10.3389\/fneur.2022.902474.","journal-title":"Front Neurol."},{"key":"1185_CR101","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/187153012800493477","volume":"12","author":"A Ergul","year":"2012","unstructured":"Ergul A, Kelly-Cobbs A, Abdalla M, Fagan SC. Cerebrovascular complications of diabetes: Focus on stroke. Endocr Metab Immune Disord. 2012;12:148\u201358. https:\/\/doi.org\/10.2174\/187153012800493477.","journal-title":"Endocr Metab Immune Disord."},{"key":"1185_CR102","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/STROKEAHA.106.481390","volume":"38","author":"T Jeerakathil","year":"2007","unstructured":"Jeerakathil T, Johnson JA, Simpson SH, Majumdar SR. Short-term risk for stroke is doubled in persons with newly treated type 2 diabetes compared with persons without diabetes: A population-based cohort study. Stroke. 2007;38:1739\u201343. https:\/\/doi.org\/10.1161\/STROKEAHA.106.481390.","journal-title":"Stroke."},{"key":"1185_CR103","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/01.cir.99.17.2239","volume":"99","author":"A Abaci","year":"1999","unstructured":"Abaci A, O\u011fuzhan A, Kahraman S, Eryol NK, Unal S, Arin\u00e7 H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239\u201342. https:\/\/doi.org\/10.1161\/01.cir.99.17.2239.","journal-title":"Circulation"},{"key":"1185_CR104","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2337\/db12-1432","volume":"62","author":"F Lizotte","year":"2013","unstructured":"Lizotte F, Par\u00e9 M, Denhez B, Leitges M, Guay A, Geraldes P. PKCd impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs. Diabetes. 2013;62:2948\u201357. https:\/\/doi.org\/10.2337\/db12-1432.","journal-title":"Diabetes."},{"key":"1185_CR105","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3171\/2015.7.JNS15218","volume":"125","author":"B Ren","year":"2016","unstructured":"Ren B, Zhang ZS, Liu WW, Bao XY, Li DS, Han C, Xian P, Zhao F, Wang H, Wang H, Duan L. Surgical outcomes following encephaloduroarteriosynangiosis in adult Moyamoya disease associated with type 2 diabetes. J Neurosurg. 2016;125:308\u201314. https:\/\/doi.org\/10.3171\/2015.7.JNS15218.","journal-title":"J Neurosurg."},{"key":"1185_CR106","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.111.261388","volume":"111","author":"JC Wang","year":"2012","unstructured":"Wang JC, Bennett M. Aging and atherosclerosis: Mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012;111:245\u201359. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.261388.","journal-title":"Circ Res."},{"issue":"99","key":"1185_CR107","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1152\/japplphysiol.00498.2005","volume":"2005","author":"AN Croley","year":"1985","unstructured":"Croley AN, Zwetsloot KA, Westerkamp LM, Ryan NA, Pendergast AM, Hickner RC, Pofahl WE, Gavin TP. Lower capillarization, VEGF protein, and VEGF mRNA response to acute exercise in the vastus lateralis muscle of aged vs young woman. J Applied Physiol. 1985;2005(99):1872\u20139. https:\/\/doi.org\/10.1152\/japplphysiol.00498.2005.","journal-title":"J Applied Physiol"},{"key":"1185_CR108","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/STROKEAHA.119.024487","volume":"50","author":"ZW Liu","year":"2019","unstructured":"Liu ZW, Han C, Zhao F, Qiao PG, Wang H, Bao XY, Zhang ZS, Yang WZ, Li DS, Duan L. Collateral circulation in Moyamoya disease: A new grading system. Stroke. 2019;50:2708\u201315. https:\/\/doi.org\/10.1161\/STROKEAHA.119.024487.","journal-title":"Stroke."},{"key":"1185_CR109","doi-asserted-by":"publisher","first-page":"861187","DOI":"10.3389\/fneur.2022.861187","volume":"13","author":"XY Bao","year":"2022","unstructured":"Bao XY, Wang QN, Wang XP, Yang RM, Zou ZX, Zhang Q, Li DS, Duan L. Recognition of the effect of indirect revascularization for Moyamoya disease: The balance between the stage progression and neoangiogenesis. Front Neurol. 2022;13:861187. https:\/\/doi.org\/10.3389\/fneur.2022.861187.","journal-title":"Front Neurol."}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-023-01185-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-023-01185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:16:18Z","timestamp":1730297778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-023-01185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":109,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s12975-023-01185-x","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics committee of the Chinese PLA General Hospital of institutional and\/or licensing committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review article, and no ethical approval is therefore required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}